首页> 外文OA文献 >Chronic inhibition of nitric-oxide synthase potentiates endothelium-dependent contractions in the rat aorta by augmenting the expression of cyclooxygenase-2
【2h】

Chronic inhibition of nitric-oxide synthase potentiates endothelium-dependent contractions in the rat aorta by augmenting the expression of cyclooxygenase-2

机译:慢性抑制一氧化氮合酶通过增加环氧合酶-2的表达增强大鼠主动脉内皮依赖性收缩

摘要

Acute inhibition of nitric-oxide synthase (NOS) unmasks the release of endothelium-derived contracting factors (EDCFs). The present study investigated whether chronic inhibition of NOS modulates endothelium-dependent contractions. Eighteen-week-old male Sprague-Dawley rats were treated by daily gavage for 6 weeks with the NOS inhibitor Nω-nitro-L-arginine methyl ester (L-NAME) (60 mg/ kg) or vehicle (distilled water; 1 ml/kg). Chronic treatment with LNAME increased arterial blood pressure. Isometric tension was measured in aortic rings with or without endothelium. Endotheliumdependent relaxations to acetylcholine and the calcium ionophore 5-(methylamino)-2-[(2R,3R,6S,8S,9R,11R)- 3,9,11-trimethyl-8-[(1S)-1-methyl-2-oxo-2-(1H-pyrrol-2-yl)-ethyl]-1, 7-dioxaspiro[5.5]undec-2-yl]methyl]-4-benzoxazolecarboxylic acid (A23187) were reduced in preparations from L-NAME-treated rats. The reduction in relaxation to A23187 was partially reversed by L-arginine (1 mM). In quiescent aortic rings, A23187 caused contractions in the presence of L-NAME and intact endothelium. The A23187-induced contractions were greater in rings from the L-NAME-treated rats than in those from the control group. These contractions were abolished by the cyclooxygenase (COX)-2 inhibitor N-[2-cyclohexyloxy-4-nitrophenyl] methanesulfonamide (NS-398) and the thromboxane-prostanoid (TP) receptor antagonist 3-((6R)-6-{[(4-chlorophenyl)sulfonyl]amido}-2-methyl-5,6,7,8- tetrahydronaphthalen-1-yl)propanoate (S18886), but not by the COX-1 inhibitor 5-(4-chlorophenyl)-1-(4-methoxyphenyl)-3-(trifluoromethyl)-1H-pyrazole (SC-560). Chronic L-NAME treatment reduced the level of nitric oxide in the plasma but increased COX activity in the aortic rings. Western blotting and immunohistochemical staining showed that endothelial NOS expression was reduced in the aortae of the chronic L-NAME-treated group. COX-1 expression was augmented slightly, whereas COX-2 expression was up-regulated markedly. The TP receptor expression was comparable with control. These experiments demonstrate that chronic NOS inhibition increases endothelium-dependent contractions of the rat aorta by inducing COX-2 expression and augmenting the production of EDCF. Copyright © 2010 by The American Society for Pharmacology and Experimental Therapeutics.
机译:一氧化氮合酶(NOS)的急性抑制掩盖了内皮来源的收缩因子(EDCFs)的释放。本研究调查了NOS的慢性抑制是否调节内皮依赖性收缩。用NOS抑制剂Nω-硝基-L-精氨酸甲酯(L-NAME)(60 mg / kg)或溶媒(蒸馏水; 1 ml)每天管饲18周龄雄性Sprague-Dawley大鼠,治疗6周/公斤)。 LNAME的长期治疗会增加动脉血压。在有或没有内皮的主动脉环中测量等轴测张力。内皮依赖性舒张到乙酰胆碱和钙离子载体5-(甲基氨基)-2-[(2R,3R,6S,8S,9R,11R)-3,9,11-三甲基-8-[(1S)-1-甲基-在由L-的制剂中还原了2-氧代-2-(1H-吡咯-2-基)-乙基] -1、7-二氧杂螺[5.5]十一-2-基]甲基] -4-苯并恶唑羧酸(A23187) NAME处理的大鼠。 L-精氨酸(1 mM)可部分逆转松弛到A23187的程度。在静态主动脉环中,A23187在存在L-NAME和完整内皮的情况下引起收缩。在L-NAME处理的大鼠的环中,A23187诱导的收缩大于对照组。这些收缩被环加氧酶(COX)-2抑制剂N- [2-环己氧基-4-硝基苯基]甲磺酰胺(NS-398)和血栓烷-前列腺素(TP)受体拮抗剂3-((6R)-6- { [(4-氯苯基)磺酰基]酰胺基} -2-甲基-5,6,7,8-四氢萘-1-基)丙酸酯(S18886),但不受COX-1抑制剂5-(4-氯苯基)- 1-(4-甲氧基苯基)-3-(三氟甲基)-1H-吡唑(SC-560)。慢性L-NAME治疗可降低血浆中一氧化氮的水平,但可增加主动脉环中的COX活性。 Western印迹和免疫组织化学染色显示,慢性L-NAME治疗组的主动脉中内皮NOS表达降低。 COX-1表达略有增加,而COX-2表达则明显上调。 TP受体表达与对照相当。这些实验证明,长期的NOS抑制作用通过诱导COX-2表达并增加EDCF的产生而增加大鼠主动脉的内皮依赖性收缩。版权所有©2010,美国药理与实验治疗学会。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号